Innovation Pharmaceuticals Inc (IPIX)

[BonelessCat]

You are misinterpreting the purpose of a BTD. Ideally it is before the end of phase 2 meeting because there is little or no benefit from a BTD approval once phase 3 is approved to start. An approved BTD after the end of phase 2 meeting would require a new meeting and resubmission of the trial design, thus eating any time advantage gained by a BTD.